NICE have recently published an updated guideline for secondary care cancer referrals (Suspected cancer: recognition and referral NG12 (1)) which updates the CG27 (2005) Referral guidelines for suspected cancer (2).
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
There have been some significant changes to the urgent (two week) referral guidance for urological cancer (see Table 1), especially with regard to the management of haematuria. On behalf of the BAUS Section of Oncology we have summarised their findings salient to our urological practice. This article is protected by copyright. All rights reserved.
BJU international. 2015 Oct 16 [Epub ahead of print]
Edward R Jefferies, Simon F Brewster, BAUS Section on Oncology
Department of Urology, Southmead Hospital, Bristol, UK. , Oxford University Hospitals NHS Trust, Oxford, UK.